Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Mar;64(3):732–738. doi: 10.1086/302278

Cyclic ichthyosis with epidermolytic hyperkeratosis: A phenotype conferred by mutations in the 2B domain of keratin K1.

V P Sybert 1, J S Francis 1, L D Corden 1, L T Smith 1, M Weaver 1, K Stephens 1, W H McLean 1
PMCID: PMC1377790  PMID: 10053007

Abstract

Bullous congenital ichthyosiform erythroderma (BCIE) is characterized by blistering and erythroderma in infancy and by erythroderma and ichthyosis thereafter. Epidermolytic hyperkeratosis is a hallmark feature of light and electron microscopy. Here we report on four individuals from two families with a unique clinical disorder with histological findings of epidermolytic hyperkeratosis. Manifesting erythema and superficial erosions at birth, which improved during the first few months of life, affected individuals later developed palmoplantar hyperkeratosis with patchy erythema and scale elsewhere on the body. Three affected individuals exhibit dramatic episodic flares of annular, polycyclic erythematous plaques with scale, which coalesce to involve most of the body surface. The flares last weeks to months. In the interim periods the skin may be normal, except for palmoplantar hyperkeratosis. Abnormal keratin-filament aggregates were observed in suprabasal keratinocytes from both probands, suggesting that the causative mutation might reside in keratin K1 or keratin K10. In one proband, sequencing of K1 revealed a heterozygous mutation, 1436T-->C, predicting a change of isoleucine to threonine in the highly conserved helix-termination motif. In the second family, a heterozygous mutation, 1435A-->T, was found in K1, predicting an isoleucine-to-phenylalanine substitution in the same codon. Both mutations were excluded in both a control population and all unaffected family members tested. These findings reveal that a clinical phenotype distinct from classic BCIE but with similar histology can result from K1 mutations and that mutations at this codon give rise to a clinically unique condition.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonifas J. M., Matsumura K., Chen M. A., Berth-Jones J., Hutchison P. E., Zloczower M., Fritsch P. O., Epstein E. H., Jr Mutations of keratin 9 in two families with palmoplantar epidermolytic hyperkeratosis. J Invest Dermatol. 1994 Oct;103(4):474–477. doi: 10.1111/1523-1747.ep12395570. [DOI] [PubMed] [Google Scholar]
  2. Bonifas J. M., Rothman A. L., Epstein E. H., Jr Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science. 1991 Nov 22;254(5035):1202–1205. doi: 10.1126/science.1720261. [DOI] [PubMed] [Google Scholar]
  3. Cheng J., Syder A. J., Yu Q. C., Letai A., Paller A. S., Fuchs E. The genetic basis of epidermolytic hyperkeratosis: a disorder of differentiation-specific epidermal keratin genes. Cell. 1992 Sep 4;70(5):811–819. doi: 10.1016/0092-8674(92)90314-3. [DOI] [PubMed] [Google Scholar]
  4. Chipev C. C., Korge B. P., Markova N., Bale S. J., DiGiovanna J. J., Compton J. G., Steinert P. M. A leucine----proline mutation in the H1 subdomain of keratin 1 causes epidermolytic hyperkeratosis. Cell. 1992 Sep 4;70(5):821–828. doi: 10.1016/0092-8674(92)90315-4. [DOI] [PubMed] [Google Scholar]
  5. Collin C., Moll R., Kubicka S., Ouhayoun J. P., Franke W. W. Characterization of human cytokeratin 2, an epidermal cytoskeletal protein synthesized late during differentiation. Exp Cell Res. 1992 Sep;202(1):132–141. doi: 10.1016/0014-4827(92)90412-2. [DOI] [PubMed] [Google Scholar]
  6. Corden L. D., McLean W. H. Human keratin diseases: hereditary fragility of specific epithelial tissues. Exp Dermatol. 1996 Dec;5(6):297–307. doi: 10.1111/j.1600-0625.1996.tb00133.x. [DOI] [PubMed] [Google Scholar]
  7. Coulombe P. A., Hutton M. E., Letai A., Hebert A., Paller A. S., Fuchs E. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell. 1991 Sep 20;66(6):1301–1311. doi: 10.1016/0092-8674(91)90051-y. [DOI] [PubMed] [Google Scholar]
  8. DiGiovanna J. J., Bale S. J. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol. 1994 Aug;130(8):1026–1035. [PubMed] [Google Scholar]
  9. Holbrook K. A., Dale B. A., Witt D. R., Hayden M. R., Toriello H. V. Arrested epidermal morphogenesis in three newborn infants with a fatal genetic disorder (restrictive dermopathy). J Invest Dermatol. 1987 Mar;88(3):330–339. doi: 10.1111/1523-1747.ep12466219. [DOI] [PubMed] [Google Scholar]
  10. Irvine A. D., Corden L. D., Swensson O., Swensson B., Moore J. E., Frazer D. G., Smith F. J., Knowlton R. G., Christophers E., Rochels R. Mutations in cornea-specific keratin K3 or K12 genes cause Meesmann's corneal dystrophy. Nat Genet. 1997 Jun;16(2):184–187. doi: 10.1038/ng0697-184. [DOI] [PubMed] [Google Scholar]
  11. Joh G. Y., Traupe H., Metze D., Nashan D., Huber M., Hohl D., Longley M. A., Rothnagel J. A., Roop D. R. A novel dinucleotide mutation in keratin 10 in the annular epidermolytic ichthyosis variant of bullous congenital ichthyosiform erythroderma. J Invest Dermatol. 1997 Mar;108(3):357–361. doi: 10.1111/1523-1747.ep12286491. [DOI] [PubMed] [Google Scholar]
  12. Johnson L. D., Idler W. W., Zhou X. M., Roop D. R., Steinert P. M. Structure of a gene for the human epidermal 67-kDa keratin. Proc Natl Acad Sci U S A. 1985 Apr;82(7):1896–1900. doi: 10.1073/pnas.82.7.1896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kimonis V., DiGiovanna J. J., Yang J. M., Doyle S. Z., Bale S. J., Compton J. G. A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J Invest Dermatol. 1994 Dec;103(6):764–769. doi: 10.1111/1523-1747.ep12412771. [DOI] [PubMed] [Google Scholar]
  14. Lane E. B., Rugg E. L., Navsaria H., Leigh I. M., Heagerty A. H., Ishida-Yamamoto A., Eady R. A. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature. 1992 Mar 19;356(6366):244–246. doi: 10.1038/356244a0. [DOI] [PubMed] [Google Scholar]
  15. McLean W. H., Eady R. A., Dopping-Hepenstal P. J., McMillan J. R., Leigh I. M., Navsaria H. A., Higgins C., Harper J. I., Paige D. G., Morley S. M. Mutations in the rod 1A domain of keratins 1 and 10 in bullous congenital ichthyosiform erythroderma (BCIE). J Invest Dermatol. 1994 Jan;102(1):24–30. doi: 10.1111/1523-1747.ep12371726. [DOI] [PubMed] [Google Scholar]
  16. McLean W. H., Morley S. M., Lane E. B., Eady R. A., Griffiths W. A., Paige D. G., Harper J. I., Higgins C., Leigh I. M. Ichthyosis bullosa of Siemens--a disease involving keratin 2e. J Invest Dermatol. 1994 Sep;103(3):277–281. doi: 10.1111/1523-1747.ep12394307. [DOI] [PubMed] [Google Scholar]
  17. McLean W. H., Rugg E. L., Lunny D. P., Morley S. M., Lane E. B., Swensson O., Dopping-Hepenstal P. J., Griffiths W. A., Eady R. A., Higgins C. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet. 1995 Mar;9(3):273–278. doi: 10.1038/ng0395-273. [DOI] [PubMed] [Google Scholar]
  18. Quinlan R., Hutchison C., Lane B. Intermediate filament proteins. Protein Profile. 1994;1(8):779–911. [PubMed] [Google Scholar]
  19. Rothnagel J. A., Dominey A. M., Dempsey L. D., Longley M. A., Greenhalgh D. A., Gagne T. A., Huber M., Frenk E., Hohl D., Roop D. R. Mutations in the rod domains of keratins 1 and 10 in epidermolytic hyperkeratosis. Science. 1992 Aug 21;257(5073):1128–1130. doi: 10.1126/science.257.5073.1128. [DOI] [PubMed] [Google Scholar]
  20. Rothnagel J. A., Traupe H., Wojcik S., Huber M., Hohl D., Pittelkow M. R., Saeki H., Ishibashi Y., Roop D. R. Mutations in the rod domain of keratin 2e in patients with ichthyosis bullosa of Siemens. Nat Genet. 1994 Aug;7(4):485–490. doi: 10.1038/ng0894-485. [DOI] [PubMed] [Google Scholar]
  21. Steinert P. M., Yang J. M., Bale S. J., Compton J. G. Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. Biochem Biophys Res Commun. 1993 Dec 15;197(2):840–848. doi: 10.1006/bbrc.1993.2555. [DOI] [PubMed] [Google Scholar]
  22. Stephens K., Ehrlich P., Weaver M., Le R., Spencer A., Sybert V. P. Primers for exon-specific amplification of the KRT5 gene: identification of novel and recurrent mutations in epidermolysis bullosa simplex patients. J Invest Dermatol. 1997 Mar;108(3):349–353. doi: 10.1111/1523-1747.ep12286486. [DOI] [PubMed] [Google Scholar]
  23. van der Schroeff J. G., van Leeuwen-Cornelisse I., van Haeringen A., Went L. N. Further evidence for localization of the gene of erythrokeratodermia variabilis. Hum Genet. 1988 Sep;80(1):97–98. doi: 10.1007/BF00451466. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES